7MM Duchenne muscle dystrophy market to greater than dual by 2033
Its extension is credited to the therapy of people with bedridden DMD. According to GlobalData, the Duchenne Muscle Mass Dystrophy (DMD) market in 7 significant markets (7mm) is anticipated to expand from $2.3 B in 2023 to $5.2 B in 2033. The sector’s development is credited to the therapy of people with bedridden DMD.
